Document is current
Any future updates will be listed below
-
Authors
Ertl, Natalie
Mills, Edouard G.
Wall, Matthew B.
Thurston, Layla
Yang, Lisa
Suladze, Sofiya
Hunjan, Tia
Phylactou, Maria
Patel, Bijal
Bassett, Paul A.
Howard, Jonathan
Rabiner, Eugenii A.
Abbara, Ali
Goldmeier, David
Comninos, Alexander N.
Dhillo, Waljit S.
-
Funding
Funding for this research was provided by:
NIHR (Clinical Lectureship Fellowship, Clinical Lectureship Fellowship, Clinician Scientist Fellowship CS-2018-18-ST2–002, Research Professorship NIHR RP-2014-05-001)
MRC (Clinical Research Training Fellowships, Clinical Research Training Fellowships)
National Health Service
- License Information
-
More Information
Article History
Received: 27 November 2023
Accepted: 2 May 2024
First Online: 14 May 2024
Competing interests
: Dr Ertl and Dr Wall reported being employed by Invicro LLC, a commercial research organization that performs contract research for the pharmaceutical and biotechnology industries, during the conduct of the studies. Dr Abbara reported receiving consulting fees from Myovant Sciences outside the submitted work. Prof Dhillo reported receiving consulting fees from Myovant Sciences and KaNDy Therapeutics outside the submitted work. No other disclosures were reported.
